Molecule Holdings Inc.
EVRRF · OTC
10/31/2022 | 10/31/2021 | 10/31/2020 | 10/31/2019 | |
|---|---|---|---|---|
| Revenue | $1,968 | $455 | $0 | $0 |
| % Growth | 332.4% | – | – | – |
| Cost of Goods Sold | $3,042 | $955 | $48 | $28 |
| Gross Profit | -$1,074 | -$500 | -$48 | -$28 |
| % Margin | -54.6% | -109.8% | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2,588 | $2,426 | $1,879 | $1,069 |
| SG&A Expenses | $2,656 | $2,454 | $1,879 | $1,069 |
| Sales & Mktg Exp. | $68 | $28 | $0 | $0 |
| Other Operating Expenses | $184 | $440 | -$49 | $28 |
| Operating Expenses | $2,840 | $2,894 | $1,830 | $1,097 |
| Operating Income | -$3,914 | -$3,192 | -$1,879 | -$1,076 |
| % Margin | -198.9% | -701.1% | – | – |
| Other Income/Exp. Net | -$630 | -$1,036 | -$1,448 | $6 |
| Pre-Tax Income | -$4,544 | -$4,227 | -$3,327 | -$1,091 |
| Tax Expense | $0 | $0 | $0 | $16 |
| Net Income | -$4,544 | -$4,227 | -$3,327 | -$1,091 |
| % Margin | -230.8% | -928.6% | – | – |
| EPS | -0.047 | -0.046 | -0.026 | -0.24 |
| % Growth | -1.7% | -76.2% | 89.1% | – |
| EPS Diluted | -0.047 | -0.046 | -0.026 | -0.24 |
| Weighted Avg Shares Out | 97,113 | 91,856 | 75,711 | 4,656 |
| Weighted Avg Shares Out Dil | 97,113 | 91,856 | 75,711 | 4,656 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $0 | $8 | $21 |
| Interest Expense | $635 | $661 | $45 | $16 |
| Depreciation & Amortization | $652 | $519 | $48 | $28 |
| EBITDA | -$3,257 | -$2,875 | -$3,234 | -$1,048 |
| % Margin | -165.5% | -631.5% | – | – |